Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain J van Gool

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
BMC Neurology|January 19, 2020
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonismsAnna Santaella, H Bea Kuiperij, Anouke van Rumund, et al.
NPJ Parkinson'S Disease|September 18, 2020
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's diseaseAnna Santaella, H Bea Kuiperij, Anouke van Rumund, et al.
Croatian Medical Journal|August 23, 2012
An integrated framework of personalized medicine: from individual genomes to participatory health careAndrea W M Evers, Maroeska M Rovers, Jan A M Kremer, et al.
Metabolism: Clinical and Experimental|May 10, 2021
Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetesAnna W M Janssen, Rinke Stienstra, Martin Jaeger, et al.
Clinical Chemistry and Laboratory Medicine|July 10, 2019
Clinical biomarker innovation: when is it worthwhile?Anouck Kluytmans, Jaap Deinum, Kevin Jenniskens, et al.
BMC Genomics|July 30, 2022
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studiesAnna Niehues, Daniele Bizzarri, Marcel J T Reinders, et al.
International Journal of Molecular Sciences|May 13, 2023
The GlycoPaSER Prototype as a Real-Time N-Glycopeptide Identification Tool Based on the PaSER Parallel Computing PlatformGad Armony, Sven Brehmer, Tharan Srikumar, et al.
Plos One|November 28, 2018
Qualitative evaluation of coronary atherosclerosis in a large cohort of young and middle-aged Dutch tissue donors implies that coronary thrombo-embolic manifestations are stochasticJan H Lindeman, Luuk Hulsbos, Antoon J van den Bogaerdt, et al.
International Journal of Obesity (2005)|October 11, 2018
Evaluation of chitotriosidase as a biomarker for adipose tissue inflammation in overweight individuals and type 2 diabetic patientsRoel Tans, Janna A van Diepen, Sabina Bijlsma, et al.
Protein Expression and Purification|May 29, 2020
Affimers as an alternative to antibodies for protein biomarker enrichmentRoel Tans, Danique M H van Rijswijck, Alex Davidson, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
BMC Neurology|January 19, 2020
Inflammation biomarker discovery in Parkinson's disease and atypical parkinsonismsAnna Santaella, H Bea Kuiperij, Anouke van Rumund, et al.
NPJ Parkinson'S Disease|September 18, 2020
Cerebrospinal fluid monocyte chemoattractant protein 1 correlates with progression of Parkinson's diseaseAnna Santaella, H Bea Kuiperij, Anouke van Rumund, et al.
Croatian Medical Journal|August 23, 2012
An integrated framework of personalized medicine: from individual genomes to participatory health careAndrea W M Evers, Maroeska M Rovers, Jan A M Kremer, et al.
Metabolism: Clinical and Experimental|May 10, 2021
Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetesAnna W M Janssen, Rinke Stienstra, Martin Jaeger, et al.
Clinical Chemistry and Laboratory Medicine|July 10, 2019
Clinical biomarker innovation: when is it worthwhile?Anouck Kluytmans, Jaap Deinum, Kevin Jenniskens, et al.
BMC Genomics|July 30, 2022
Metabolomic predictors of phenotypic traits can replace and complement measured clinical variables in population-scale expression profiling studiesAnna Niehues, Daniele Bizzarri, Marcel J T Reinders, et al.
International Journal of Molecular Sciences|May 13, 2023
The GlycoPaSER Prototype as a Real-Time N-Glycopeptide Identification Tool Based on the PaSER Parallel Computing PlatformGad Armony, Sven Brehmer, Tharan Srikumar, et al.
Plos One|November 28, 2018
Qualitative evaluation of coronary atherosclerosis in a large cohort of young and middle-aged Dutch tissue donors implies that coronary thrombo-embolic manifestations are stochasticJan H Lindeman, Luuk Hulsbos, Antoon J van den Bogaerdt, et al.
International Journal of Obesity (2005)|October 11, 2018
Evaluation of chitotriosidase as a biomarker for adipose tissue inflammation in overweight individuals and type 2 diabetic patientsRoel Tans, Janna A van Diepen, Sabina Bijlsma, et al.
Protein Expression and Purification|May 29, 2020
Affimers as an alternative to antibodies for protein biomarker enrichmentRoel Tans, Danique M H van Rijswijck, Alex Davidson, et al.
Pageof 6